|4Jun 8, 6:42 PM ET

Lis William 4

4 · Jasper Therapeutics, Inc. · Filed Jun 8, 2023

Insider Transaction Report

Form 4
Period: 2023-06-07
Lis William
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-07+47,00047,000 total
    Exercise: $1.60From: 2024-06-07Exp: 2033-06-07Voting Common Stock (47,000 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary